Mode
Text Size
Log in / Sign up
Phase 1 N=30 Randomized Treatment

Modeling Mood Course to Detect Markers for Effective Adaptive Interventions- Aim 3

Bipolar Disorder · Psychosocial Intervention

Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Jan 2022
Primary outcome: Primary: Number of Shortened YMRS Surveys Completed — 1651 completed surveys

Study Design & Population

Study type
Interventional
Phase
Phase 1
Interventions
Mobile intervention (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Wisconsin, Madison
Primary completion
Oct 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Shortened YMRS Surveys Completed
1651
PRIMARY
Number of Shortened SIGHD Surveys Completed
1651
PRIMARY
Change in YMRS Score
-1.2 0.09
PRIMARY
Change in SIGH-D Score
2.1 0.09
SECONDARY
Average Change in m Score on digiBP From One Decision Time Point to the Next Decision Time Point as a Result of the Intervention
0.14 0.13
SECONDARY
Average Change in d Score on digiBP From One Decision Time Point to the Next Decision Time Point as a Result of the Intervention
0.38 0.007 sig
SECONDARY
Average Change in Toward Energy Score From One Decision Time Point to the Next Decision Time Point as a Result of the Intervention
0.03 0.57
SECONDARY
Average Change in Away Energy Score From One Decision Time Point to the Next Decision Time Point as a Result of the Intervention
0.06 0.25

Summary

This study is a 6-week micro-randomized trial investigating the feasibility of a mobile health platform. Its long-term objective is to develop a mobile health platform for the translation of a psychosocial intervention for bipolar disorder (BP) into an effective and evidence-based adaptive intervention. In this aim of the study, investigators will evaluate how individuals with BP respond to a microintervention based in acceptance and commitment therapy (ACT) that is delivered with a mobile app.

Eligibility Criteria

Inclusion Criteria

  • Individuals diagnosed with Bipolar Disorder
  • have agreed to be contacted for future research
  • have a smart-phone
  • have a diagnosis of bipolar disorder.

Exclusion Criteria

-

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04098497). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search